Virogenix Pharma
Driven by Science,
Inspired by Patients
Innovation,
Health,
Humanity.
What We Stand For
Overview
Our focus is on harnessing cutting-edge research and technology to develop targeted therapies that address the unique biology of different cancer types.
Our oncology pipeline spans across various modalities, including small molecules, biologics, immunotherapies, and precision medicine approaches, with the goal of tackling both common and rare cancers. By leveraging deep insights into tumor genetics and the tumor microenvironment, we aim to provide treatments that not only target cancer cells directly but also enhance the body's immune response, offering personalized and effective treatment options
1
Rubicell-L
Dosage and Administration
Doxorubicin (Liposomal) is an anti-cancer medication. It works by damaging the genetic material (DNA) of the cancer cells and stops their growth and multiplication.The recommended dose of Liposomal doxorubicin intravenously (IV) single dose in a every four week. Discard unused portion.
2
Docetax
Dosage and Administration
Docel 120mg Injection is an anti-cancer medication used for the treatment of breast cancer, non-small cell lung cancer, prostate cancer and cancers of head and neck. The recommended dose of docetaxel administered over 1hr every three weeks . Discard unused portion.
3
Vorinact
Dosage and Administration
The recommended dose of PEG – Aspraginaz is 3750 International Units/m² intramuscularly (IM) or intravenously (IV) three times a week. When PEG – Aspraginaz is administered IM, the volume at a single injection site should be limited to 2 mL. If a volume greater than 2 mL is to be administered, two injection sites should be used. Discard unused portion.
Product under development
